Search - tctmd.com

Displaying 541 - 560 of 928

Sort: Relevancy | Date

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Todd Neale

November 27, 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Todd Neale

November 17, 2019

Presentation Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

Presentation TCT 2019

Belarus Presents: Minimally Invasive Hybrid Approach to Direct Device LV Remodeling in Patient With Ischemic Cardiomyopathy

Presenter: Oleg Polonetsky

September 28, 2019

Presentation TCT 2019

Long-term Outcomes of Alcohol Septal Ablation

Presenter: George Hanzel

September 28, 2019

Presentation TCT 2019

Alcohol Septal Ablation Complications and Management

Presenter: Hubert Seggewiss

September 28, 2019

Presentation TCT 2019

The Alcohol Septal Ablation Procedure

Presenter: Valerian Fernandes

September 28, 2019

Presentation TCT 2019

Case Selection for Alcohol Septal Ablation

Presenter: Srihari Naidu

September 28, 2019

Presentation TCT 2019

Clinical Presentation, Pathophysiology, and Natural History

Presenter: Bernard Gersh

September 28, 2019

Presentation TCT 2019

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Presenter: Bernard Gersh

September 28, 2019

Presentation TCT 2019

Medical Treatments for HCM

Presenter: Carey Kimmelstiel

September 28, 2019

Presentation TCT 2019

Imaging in HCM for Diagnosis and Risk Stratification

Presenter: Sherif Nagueh

September 28, 2019

Presentation TCT 2019

Orbital Atherectomy for Coronary Calcification: When and How

Presenter: Richard Shlofmitz

September 28, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

Session I: Innovation and Practice in Structural Heart Intervention - Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Presentation TCT 2019

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Liwen Liu

September 25, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

Advertisement

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Echo imaging in HFpEF

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Belarus Presents: Minimally Invasive Hybrid Approach to Direct Device LV Remodeling in Patient With Ischemic Cardiomyopathy

Long-term Outcomes of Alcohol Septal Ablation

Alcohol Septal Ablation Complications and Management

The Alcohol Septal Ablation Procedure

Case Selection for Alcohol Septal Ablation

Clinical Presentation, Pathophysiology, and Natural History

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Medical Treatments for HCM

Imaging in HCM for Diagnosis and Risk Stratification

Orbital Atherectomy for Coronary Calcification: When and How

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content